W Nathaniel Brennen

28PUBLICATIONS
136CO-AUTHORS
Molecular targetsPredictive and prognostic markersComputational imagingHaematological tumoursMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target.

|Dec 11, 2025
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.

Srushti Kittane, Erik Ladewig, Taibo Li

|Nov 21, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.

Rajendra Kumar, Sheila Jonnatan, David E Sanin

|Jun 19, 2024
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.

Mannan Nouri, Andreas Varkaris, Maya Ridinger

|Apr 15, 2024
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models.

Sumer Jasmine, Adel Mandl, Timothy E G Krueger

|Apr 04, 2024
The Hallmarks of Precancer.

Mary M Stangis, Zhengyi Chen, Jimin Min

Pageof 5

Frequent Collaborators

13 joint publications

John T Isaacs

5 joint publications

Samuel R Denmeade

4 joint publications

Angelo M De Marzo

3 joint publications

Susan L Dalrymple